A Weekly Pharma Programmatic Optimization Framework
A weekly optimization routine for pharma programmatic built on a decision journal: expected effect, risk, and evaluation date for every change.
The short answer
Weekly optimization is where most programmatic value is protected or lost. Done well, it catches problems early and moves budget toward what works. Done poorly, it becomes a series of reactive changes nobody can explain later. A simple framework built on a decision journal keeps optimization disciplined.
The weekly routine
1. Health check (15 minutes)
- Pacing by line item and partner.
- Quality: viewability, invalid traffic, brand safety incidents.
- Audience delivery against the target list.
- Inventory mix changes.
Anything outside tolerance goes to diagnosis, not immediate action. See underdelivery and overpacing.
2. Review past changes (15 minutes)
Look at changes whose evaluation date has arrived. Did they have the expected effect? Record the result.
3. Propose new changes (20 minutes)
For each proposed change, fill in a decision journal entry.
4. Approve and log (10 minutes)
The accountable owner approves changes. Everything goes in the journal.
The decision journal
| Field | Example |
|---|---|
| Date | Week 6 |
| Change | Shift 15% of budget from Partner B to Partner A |
| Reason | Partner A shows higher verified list reach at lower effective cost |
| Expected effect | Increase verified reach by about 8% with flat spend |
| Risk | Partner A may hit frequency caps; watch distribution |
| Evaluation date | Week 8 |
| Result | Recorded at week 8 |
The journal makes optimization accountable. It also makes wrap analysis far easier, because every major shift has a recorded reason.
Rules that keep optimization honest
- One major change per line at a time. Otherwise you cannot tell which change caused which effect.
- Minimum data before acting. Set thresholds so changes are not made on a few hundred impressions.
- Do not optimize to weak signals. Clicks are noisy for HCP. See HCP engagement metrics.
- Protect holdouts and tests. Optimization should not disrupt a measurement design.
- Do not trade away safeguards. See the campaign planning guide.
Connect to cost efficiency
Where possible, look at effective cost per quality, on-target impression, not just CPM. See why a cheap CPM can be expensive.
When to escalate
If the weekly review finds a problem that cannot be fixed within agreed limits, escalate through the partner escalation framework.
Practical takeaway
Keep one decision journal per campaign, shared with the brand. Review past entries before proposing new ones. After a few months, the journal becomes the most useful document you have about what works.
Sources
- Media Rating Council, Standards and Guidelines
- American Statistical Association, Statement on p-Values
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.